
INVO Fertility Inc NAYA.OQ NAYA.O is expected to report resultson April 21 (estimated) for the period ending December 31 2024
The Sarasota Florida-based company is expected to report revenue of $1.5 million, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for INVO Fertility Inc is for a loss of $3.48 per share.
The one available analyst rating on the shares is "buy".
The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "Buy".
Wall Street's median 12-month price target for INVO Fertility Inc is $24.00, above its last closing price of $1.92.
This summary was machine generated April 18 at 11:31 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)